Medical College of Wisconsin
676
110
168
342
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
113 terminated/withdrawn out of 676 trials
75.2%
-11.4% vs industry average
6%
40 trials in Phase 3/4
48%
163 of 342 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (676)
Blinatumomab Consolidation in Real World
Role: lead
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
Role: lead
Mechanisms Underlying Late-Life Prolonged Grief Disorder
Role: lead
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
Role: lead
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
Role: lead
Measurement of Feeding Experience for Infants With Non-Oral Feedings
Role: lead
Estrogen and Microvascular Function
Role: lead
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
Role: lead
Transcranial Alternating Current Stimulation (tACS) in Aphasia
Role: lead
Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity
Role: collaborator
Voice-activated and Touchscreen-controlled Smart Speaker Intervention for Older Adults With Poorly Controlled Type 2 Diabetes
Role: lead
Probiotics for Inflammation in Pediatric Chronic Pain
Role: lead
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Role: lead
Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Role: lead
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Role: lead
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
Role: lead
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Role: collaborator
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
Role: collaborator
Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
Role: lead
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
Role: lead